Manufacturer: INTAS
Pharmaceutical name: Etizolam
Pack: 100 pills (1 mg)
Etilaam is a medication belonging to the thienobenzodiazepine class, containing Etizolam. It functions as an anxiolytic, sedative-hypnotic, and antidepressant. Etilaam is prescribed for oral therapy aimed at treating anxiety disorders, including panic attacks and generalized anxiety, as well as depression in adult patients. It is also beneficial for the short-term management of insomnia. Etilaam serves as an anti-convulsant, helping to relax skeletal muscles and address various medical issues. It has selectivity and a strong affinity for the alpha2 subunit of the postsynaptic GABA receptor.
Etilaam contains Etizolam, which exhibits anti-convulsant-like properties. Etizolam is also given to patients for short-term insomnia treatment. Furthermore, it proves helpful for managing situational anxiety conditions, such as panic attacks and phobic neurosis. Etilaam tablets are utilized in the treatment of secondary psychosomatic conditions, including headaches, irritable bowel syndrome (IBS), and hypertension.
The maximum allowable daily dosage of Etilaam should not surpass 3 mg. For anxiety disorders, the recommended dosage is 0.25-0.5 mg of Etizolam taken twice daily. For panic disorders, a suggested dosage is 0.5 mg twice daily. For patients with insomnia, doctors typically recommend a dosage of 1-2 mg of Etizolam at bedtime.
A treatment regimen involving Etilaam should not extend beyond 12 weeks. It is important to consult your doctor before stopping the treatment course with Etilaam. The cessation of Etilaam should not be done abruptly; instead, the dosage should be gradually reduced to prevent any unnecessary withdrawal symptoms.
Cardiovascular System: reduced heart rate, hypotension, bradycardia. Central Nervous System: drowsiness, sedation, ataxia, vertigo, headache, confusion, depression, slurred speech, coma. Eye and ENT: visual disturbances, involuntary eye movements, and eyelid closure. Gastrointestinal System: alterations in salivation, nausea, vomiting, and dry mouth. Genitourinary System: changes in libido, urinary retention, and gastrointestinal disturbances. Musculoskeletal System: muscle weakness and relaxation. General: amnesia, reduced appetite, and respiratory depression.